Although unstimulated moDC from CML patients and healthy donors express similar levels of co-stimulatory molecules [33,56], decreased CD80, CD83 and CD40 expression have been observed on cDC2s isolated from CML patients [32]. This evidence concerns the gene CD80 and chronic myelogenous leukemia, BCR-ABL1 positive.